David Harel is the founder of CytoReason. He leads the company's mission to quantify the human immune system at a cellular level using machine learning.
David Harel is the Co-founder and CEO of CytoReason, an Israeli biotech startup founded in 2016 that combines immunology and AI to develop better drugs. He leads the company's mission to quantify the human immune system at a cellular level using machine learning to facilitate drug discovery for cancer, autoimmune, and neurodegenerative diseases. Harel is a scientist and researcher with background connections to Technion and Stanford, which were founding institutions of CytoReason.
Full founder directory · Investor directory · Company funding database · Fundraising library